← ANALYSTS · TIPRANKS
Faisal Khurshid · Jefferies
Hits
66%
97 of 147 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+74.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
24
Buy / hold / sell: 22 / 2 / 0
Upside of the analyst’s targets
+83.2%
Average over 22 current targets, to the last price
The market’s answer to the ratings
+3.1%
Day-0 move against SPY in the rating’s direction, average over 19 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 9on TipRanks Oct 12 02:07 | VCREVicore Pharma Holding AB Sponsored ADR · $254M | Initiated | Buy | $25.00 | +178.4% | +1.4%next day +2.6% · 5 days +1.7% | ↗ |
| Sep 29on TipRanks 10:40 | SMMTSummit Therapeutics · $12.4B | Reiterated | Buy | — | — | +6.1%next day +3.4% · 5 days +3.7% | ↗ |
| Sep 8on TipRanks 06:50 | ALNYQQQAlnylam Pharma · $31.3B | Reiterated | Hold | $230 → $260+13.0% | +12.2% | −1.7%next day −0.3% · 5 days −7.3% | ↗ |
| Sep 3on TipRanks 10:05 | RVMDRevolution Medicines · $41.5B | Reiterated | Buy | $270 | +51.7% | −0.3%next day 0.0% · 5 days −2.2% | ↗ |
| Aug 31on TipRanks 09:10 | ASNDAscendis Pharma · $13.9B | Reiterated | Buy | $333 → $330−0.9% | +46.5% | +6.4%next day −0.4% · 5 days +2.8% | ↗ |
| Aug 25on TipRanks 13:40 | IMTXImmatics · $1.1B | Assigned | Buy | $18.00 → $17.00−5.6% | +152.6% | +6.0%next day +2.0% · 5 days +2.6% | ↗ |
| Aug 17on TipRanks Aug 18 04:00 | EYPTIWMEyePoint Pharmaceuticals · $271M | Reiterated | Buy | $30.00 → $8.00−73.3% | +167.6% | −66.5%next day +13.0% · 5 days +1.2% | ↗ |
| Aug 6on TipRanks 14:50 | INSMInsmed · $21.5B | Reiterated | Buy | $160 → $175+9.4% | +81.8% | +34.0%next day −1.7% · 5 days −5.9% | ↗ |
| Jul 31on TipRanks 14:45 | GLUEIWMMonte Rosa Therapeutics · $863M | Reiterated | Buy | $25.00 | +156.7% | −27.9%next day −8.3% · 5 days −7.4% | ↗ |
| Jul 12on TipRanks 20:25 | ONCBeOne Medicines · $40.3B | Upgrade | Buy | $333 → $380+14.1% | +3.0% | +2.5%next day +0.5% · 5 days +3.1% | ↗ |
| Jul 1on TipRanks Jun 30 16:15 | ABVXAbivax SA Sponsored ADR · $8.6B | Upgrade | Buy | $158 | +79.3% | −0.4%next day +9.3% · 5 days +5.4% | ↗ |
| Jun 30on TipRanks 08:45 | VRDNIWMViridian Therapeutics · $2.2B | Reiterated | Buy | $30.00 | +57.6% | −3.0%next day +0.7% · 5 days +8.3% | ↗ |
| Jun 23on TipRanks 08:40 | VSTMIWMVerastem · $836M | Reiterated | Buy | $15.00 → $8.00−46.7% | −7.5% | +0.5%next day −8.5% · 5 days −11.1% | ↗ |
| May 27on TipRanks 09:00 | PTCTIWMPTC Therapeutics · $5.1B | Upgrade | Buy | $76.00 → $85.00+11.8% | +43.5% | +4.5%next day 0.0% · 5 days −3.3% | ↗ |
| May 1on TipRanks 15:25 | SNDXIWMSyndax Pharmaceuticals · $1.2B | Reiterated | Buy | $40.00 → $37.00−7.5% | +186.8% | −11.1%next day +4.8% · 5 days +10.1% | ↗ |
| Mar 30on TipRanks 09:10 | FDMTIWM4D Molecular Therapeutics · $711M | Initiated | Buy | $40.00 → $21.00−47.5% | +73.0% | −7.8%next day +5.7% · 5 days +15.2% | ↗ |
| Mar 16on TipRanks 09:30 | COGTIWMCogent Biosciences · $4.9B | Initiated | Buy | $55.00 | +86.3% | +3.9%next day −1.0% · 5 days +1.0% | ↗ |
| Mar 15on TipRanks Mar 16 09:30 | KYMRIWMKymera Therapeutics · $9.0B | Initiated | Buy | $110 | +5.0% | −0.3%next day +1.8% · 5 days −1.5% | ↗ |
| Mar 15on TipRanks Mar 16 05:25 | INCYSPYIncyte · $23.0B | Downgrade | Hold | $94.00 | −16.9% | −0.5%next day +1.0% · 5 days −1.0% | ↗ |
| Mar 15on TipRanks 20:30 | DSGNIWMDesign Therapeutics · $656M | Initiated | Buy | $10.01 → $15.00+49.9% | +45.5% | +7.6%next day +0.2% · 5 days −5.7% | ↗ |
| Dec 15on TipRanks 09:40 | CTNMIWMContineum Therapeutics, Inc. Class A · $297M | Reiterated | Buy | $22.00 → $21.00−4.5% | +196.6% | −0.3%next day 0.0% · 5 days +5.0% | ↗ |
| Oct 22on TipRanks May 13 07:35 | LKFTLakefront Biotherapeutics · $1.9B | Upgrade | Buy | $29.00 → $40.00+37.9% | +33.8% | +1.9%next day −0.1% · 5 days −5.9% | ↗ |
| Oct 10on TipRanks 12:05 | MNKDIWMMannKind · $971M | Initiated | Buy | $9.00 | +196.1% | −2.4%next day +3.0% · 5 days +10.3% | ↗ |
| Sep 30on TipRanks Oct 2 08:25 | ZURAIWMZura Bio · $423M | Reiterated | Buy | — | — | +44.4%next day −7.0% · 5 days −8.3% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗